FDA-cleared EsoGuard/EsoCheck screening, Medicare coverage catalysts, Q3 results, VA contract and risks. Click here to read.
Tapestry stock gets a "Sell" rating after an 80% rally as momentum outpaces fundamentals. Here's what investors need to know.
With IPOs, timing is everything, and many action items should be considered well in advance of engaging an investment bank.
The sequel to 2019's more interesting Code Vein, Code Vein 2 tells a new story only loosely connected to the original, ...
Beyond the change in tone, Trump has also signaled a shift in personnel in Minneapolis.
Thank you, Zack, and thanks to everyone for joining our call. First, our quarterly financial results were solid with Q1 total ...
Crane Company ("Crane," NYSE: CR) today announced its financial results for the fourth quarter of 2025 and initiated its full-year 2026 adjusted EPS outlook. Max Mitchell, Crane's Chairman, President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results